A Mutation in the Human Glucocerebrosidase Gene in Neuronopathic Gaucher's Disease

New England Journal of Medicine

Volumn 316, Issue 10, 1987, Pages 570-575

  Tsuji, Shoji ^a,b,c   Choudary, Prabhakara V ^a,b,c   Martin, Brian M ^a,b,c   Stubblefield, Barbara K ^a,b,c   Mayor, June A ^a,b,c   Barranger, John A ^a,b,c   Ginns, Edward I ^a,b,c  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSYLCERAMIDASE;

CLINICAL ARTICLE; DIAGNOSIS; ETIOLOGY; GAUCHER DISEASE; GENETIC ENGINEERING; GENETIC MARKER; HEREDITY; HUMAN; MOLECULAR CLONING; MUTATION; PRIORITY JOURNAL;

EID: 0023131172     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198703053161002     Document Type: Article

References (43)

1. Patrick AD. A deficiency of glucocerebrosidase in Gaucher's disease. Biochem J 1965; 97: Suppl: 17c–18c.
2. Brady RO, Kanfer JN, Shapiro D. Metabolism of glucocerebrosides. II. Evidence of an enzymatic deficiency in Gaucher's disease. Biochem Biophys Res Commun 1965; 18: 221–5.
3. Brady RO, Barranger JA. Glucosylceramide lipidosis: Gaucher's disease. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS, eds. The metabolic basis of inherited disease. 5th ed. New York: McGraw-Hill, 1983:842–56.
4. Ginns EI, Brady RO, Pirruccello S, et al. Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes of Gaucher disease. Proc Natl Acad Sci USA 1982; 79: 5607–10.
5. Ginns EI, Tegelaers FPW, Barneveld R, et al. Determination of Gaucher's disease phenotypes with monoclonal antibody. Clin Chim Acta 1983; 131: 283–7.
6. Erickson AH, Ginns EI, Barranger JA. Biosynthesis of the lysosomal enzyme glucocerebrosidase. J Biol Chem 1985; 260: 14319–24.
7. Ginns EI. The molecular biology of the sphingolipid hydrolases. Bioessays 1985; 2: 118–22.
8. Ginns EI, Laszlow DJ, Moore C, Brady RO, Barranger JA. Characterization of lysosomal glucocerebrosidase in normal and Gaucher's disease tissues. Fed Proc 1983; 42: 1912. abstract.
9. Jonsson LV, Murray GJ, Ginns EI, et al. Processing of βglucocerebrosidase in fibroblasts. Fed Proc 1985; 44: 709. abstract.
10. Gravel RA, Leung A. Complementation analysis in Gaucher disease using single cell microassay techniques. Evidence for a single “Gaucher gene.” Hum Genet 1983; 65: 112–6.
11. Wenger DA, Roth S, Kudoh T, et al. Biochemical studies in a patient with subacute neuropathic Gaucher disease without visceral glucosylceramide storage. Pediatr Res 1983; 17: 344–8.
12. Kolodny EH, Ullman MD, Mankin HJ, Raghavan SS, Topol J, Sullivan JL. Phenotypic manifestations of Gaucher disease: clinical features in 48 biochemically verified type 1 patients and comment on type 2 patients. In: Desnick RJ, Gatt S, Grabowski GA, eds. Gaucher disease: a century of delineation and research: proceedings of the First International Symposium on Gaucher disease, held in New York City, July 22–24, 1981. New York: Alan R Liss, 1982:33–65.
13. Ginns EI, Choudary PV, Martin BM, et al, Isolation of cDNA clones for human β-glucocerebrosidase using the λgt11 expression system. Biochem Biophys Res Commun 1984; 123: 574–80.
14. Sorge J, Gelbart T, West C, Westwood B, Beutler E. Heterogeneity in type I Gaucher disease demonstrated by restriction mapping of the gene. Proc Natl Acad Sci USA 1985; 82: 5442–5.
15. Sorge J, West C, Westwood B, Beutler E. Molecular cloning and nucleotide sequence of human glucocerebrosidase cDNA. Proc Natl Acad Sci USA 1985; 82: 7289–93.
16. Correction of: Sorge J, West C, Westwood B, Beutler E. Molecular cloning and nucleotide sequence of human glucocerebrosidase cDNA. Proc Natl Acad Sci USA 1986; 83: 3567.
17. Tsuji S, Choudary PV, Martin BM, Winfield S, Barranger JA, Ginns EI. Nucleotide sequence of cDNA containing the complete coding sequence for human lysosomal glucocerebrosidase. J Biol Chem 1986; 261: 50–3.
18. Ginns EI, Choudary PV, Tsuji S, et al. Gene mapping and leader polypeptide sequence of human glucocerebrosidase: implications for Gaucher disease. Proc Natl Acad Sci USA 1985; 82: 7101–5.
19. Choudary PV, Ginns EI, Barranger JA. Molecular cloning and analysis of the human β-glucocerebrosidase gene. DNA 1985; 4: 74. abstract.
20. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory, 1982.
21. Frischauf A-M, Lehrach H, Poustka A, Murrary N. Lambda replacement vectors carrying polylinker sequences. J Mol Biol 1983; 170: 827–42.
22. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463–7.
23. Chen EY, Seeburg PH. Supercoil sequencing: a fast and simple method for sequencing plasmid DNA. DNA 1985; 4: 165–70.
24. Biggin MD, Gibson TJ, Hong GF. Buffer gradient gels and 35S label as an aid to rapid DNA sequence determination. Proc Natl Acad Sci USA 1983; 80: 3963–5.
25. Beaucage SL, Caruthers MH. Deoxynucleoside phosphoramidites — a new class of key intermediates for deoxypolynucleotide synthesis. Tetrahedron Lett 1981; 22: 1859–62.
26. Matteucci MD, Caruthers MH. Synthesis of deoxyoligonucleotides on a polymer support. J Am Chem Soc 1981; 103: 3185–9.
27. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 503–17.
28. Wahl GM, Stern M, Stark GR. Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl-paper and rapid hybridization by using dextran sulfate. Proc Natl Acad Sci USA 1979; 76: 3683–7.
29. Studencki AB, Wallace RB. Allele-specific hybridization using oligonucleotide probes of very high specific activity: discrimination of the human βA- and β-s-globin genes. DNA 1984; 3: 7–15.
30. Nukiwa T, Brantly M, Garver R, et al. Evaluation of “at risk” alpha 1-antitrypsin genotype SZ with synthetic oligonucleotide gene probes. J Clin Invest 1986; 77: 528–37.
31. Denhardt DT. A membrane-filter technique for the detection of complementary DNA. Biochem Biophys Res Commun 1966; 23: 641–6.
32. Garnier J, Osguthorpe DJ, Robson B. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol 1978; 120: 97–120.
33. Tsuji S, Choudary PV, Martin BM, et al. Characterization of human glucocerebrosidase genes: identification of a mutation in Gaucher disease. Am J Hum Genet 1986; 39: A222. abstract.
34. Dinur T, Osiecki KM, Legler G, Gatt S, Desnick RJ, Grabowski GA. Human acid β-glucosidase: isolation and amino acid sequence of a peptide containing the catalytic site. Proc Natl Acad Sci USA 1986; 83: 1660–4.
35. Legler G, Harder A. Amino acid sequence at the active site of β-glucosidase A from bitter almonds. Biochim Biophys Acta 1978; 524: 102–8.
36. Kleihauer EF, Reynolds CA, Dozy AM, et al. HemoglobinBibba or α2136Proβ2, an unstable α chain abnormal hemoglobin. Biochim Biophys Acta 1968; 154: 220–2.
37. Sansone G, Carrell RW, Lehmann H. Haemoglobin Genova: β28 (B10) Leucine→Proline. Nature 1967; 214: 877–9.
38. Goossens M, Lee KY, Liebhaber SA, Kan YW. Globin structural mutant α125Leu→Pro is a novel cause of α-thalassaemia. Nature 1982; 296: 864–5.
39. Spritz RA, Jagadeeswaran P, Choudary PV, et al. Base substitution in an intervening sequence of a β+-thalassemic human globin gene. Proc Natl Acad Sci USA 1981; 78: 2455–9.
40. Busslinger M, Moschonas N, Flavell RA. β+ Thalassemia: aberrant splicing results from a single point mutation in an intron. Cell 1981; 27: 289–98.
41. Baglioni C. The fusion of two peptide chains in hemoglobin lepore and its interpretation as a genetic deletion. Proc Natl Acad Sci USA 1962; 48: 1880–6.
42. Orkin SH. Old J, Lazarus H, et al. The molecular basis of α-thalassemias: frequent occurrence of dysfunctional a loci among non-Asians with Hb H disease. Cell 1979; 17: 33–42.
43. Phillips JA III, Vik TA, Scott AF, et al. Unequal crossing-over: a common basis of single a-globin genes in Asians and American blacks with hemoglobin-H disease. Blood 1980; 55: 1066–9.